These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36209201)

  • 21. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
    Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
    Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
    Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway.
    Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
    Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
    Park JH; Ryu JM; Han HJ
    J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway.
    Hu C; Zhou H; Liu Y; Huang J; Liu W; Zhang Q; Tang Q; Sheng F; Li G; Zhang R
    Int J Oncol; 2019 Oct; 55(4):833-844. PubMed ID: 31485605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
    Xia H; Li Y; Lv X
    Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.
    Xu Z; Wang R; Li X; Yang L; Peng H; Wang Y; Wang P
    J Mol Histol; 2021 Jun; 52(3):503-510. PubMed ID: 33515112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
    Yousif NG
    Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways.
    Guan L; Zhang L; Wang T; Jia L; Zhang N; Yan H; Zhao K
    Cancer Biomark; 2021; 32(3):293-302. PubMed ID: 34151840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway.
    Zhou X; Gu R; Han X; Wu G; Liu J
    Biochem Biophys Res Commun; 2017 Oct; 492(3):447-452. PubMed ID: 28842255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rab22a promotes the proliferation, migration, and invasion of lung adenocarcinoma via up-regulating PI3K/Akt/mTOR signaling pathway.
    Wang J; Luo X; Lu J; Wang X; Miao Y; Li Q; Wang L
    Exp Cell Res; 2022 Jul; 416(2):113179. PubMed ID: 35487271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.
    Zhao H; Chen G; Ye L; Yu H; Li S; Jiang WG
    Int J Oncol; 2019 Jan; 54(1):381-389. PubMed ID: 30431081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer.
    Dong Y; Xu T; Li D; Guo H; Du X; Li G; Chen J; Wang B; Wang P; Yu G; Zhao X; Xue R
    Bioengineered; 2022 Jun; 13(6):14413-14425. PubMed ID: 36694434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
    Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.